Robinson, Andrew
Stober, Carol
Fergusson, Dean
Kehoe, Anne
Bedard, Debbie
MacDonald, Fiona
Brunet, Marie-Claude
Saunders, Deanna
Mazzarello, Sasha
Vandermeer, Lisa
Joy, Anil A.
Awan, Arif
Basulaiman, Bassam
Mallick, Ranjeeta
Hutton, Brian
Clemons, Mark http://orcid.org/0000-0002-0738-2713
,
Clinical trials referenced in this document:
Documents that mention this clinical trial
A multicentre, randomized pilot trial comparing vascular access strategies for early stage breast cancer patients receiving non-trastuzumab containing chemotherapy
https://doi.org/10.1007/s10549-019-05388-5
Article History
Received: 26 July 2019
Accepted: 31 July 2019
First Online: 7 August 2019
Compliance with ethical standards
:
: Dr. Awan reports participating in the Novartis Canada Advisory Board on the use of Ribociclib. Dr. Hutton reports personal fees from Cornerstone Research, outside the submitted work. The remaining authors declare that they have no conflicts of interest (Robinson, Stober, Fergusson, Kehoe, Bedard, MacDonald, Brunet, Saunders, Mazzarello, Vandermeer, Joy, Basulaiman, Mallick, and Clemons).
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.